[go: up one dir, main page]

HK1110215B - 用於治疗疾病或病情的液体制剂 - Google Patents

用於治疗疾病或病情的液体制剂 Download PDF

Info

Publication number
HK1110215B
HK1110215B HK08103742.7A HK08103742A HK1110215B HK 1110215 B HK1110215 B HK 1110215B HK 08103742 A HK08103742 A HK 08103742A HK 1110215 B HK1110215 B HK 1110215B
Authority
HK
Hong Kong
Prior art keywords
rapamycin
vitreous
peg
rapa
eye
Prior art date
Application number
HK08103742.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1110215A1 (zh
Inventor
Sreenivasu Mudumba
Philippe J. M. Dor
Thierry Nivaggioli
David A. Weber
Sidiq Mohammed Farooq
Original Assignee
Santen Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co., Ltd. filed Critical Santen Pharmaceutical Co., Ltd.
Priority claimed from PCT/US2006/004962 external-priority patent/WO2006086750A1/en
Publication of HK1110215A1 publication Critical patent/HK1110215A1/zh
Publication of HK1110215B publication Critical patent/HK1110215B/zh

Links

HK08103742.7A 2005-02-09 2006-02-09 用於治疗疾病或病情的液体制剂 HK1110215B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US65179005P 2005-02-09 2005-02-09
US60/651,790 2005-02-09
US66430605P 2005-03-21 2005-03-21
US66404005P 2005-03-21 2005-03-21
US60/664,306 2005-03-21
US60/664,040 2005-03-21
PCT/US2006/004962 WO2006086750A1 (en) 2005-02-09 2006-02-09 Liquid formulations for treatment of diseases or conditions

Publications (2)

Publication Number Publication Date
HK1110215A1 HK1110215A1 (zh) 2008-07-11
HK1110215B true HK1110215B (zh) 2016-08-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP1848431B1 (en) Liquid formulations for treatment of diseases or conditions
KR101478164B1 (ko) 안정한 제제와 그 제조 및 사용 방법
CN112135603B (zh) 包含奈必洛尔的药物组合物
KR20100055482A (ko) 안질환 또는 안이상의 치료를 위한 제제
BRPI0709016A2 (pt) formulações e métodos para doenças ou condições relacionadas com a permeabilidade vascular
KR20160135372A (ko) 리셉터 티로신 키나제 저해(ＲＴＫｉ) 화합물을 눈에 전달하기 위한 약학 조성물
JP2021518352A (ja) チモロールを含む医薬組成物
Gautam et al. Intracameral drug delivery: a review of agents, indications, and outcomes
CN114449999A (zh) 用于治疗葡萄膜炎的眼用组合物
KR20150100670A (ko) 레고라페닙을 함유하는 국소 안과 제약 조성물
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
CN115867264A (zh) 局部眼科组合物和治疗异常血管新生的方法
HK1110215B (zh) 用於治疗疾病或病情的液体制剂
PT1682131E (pt) Cci-779 para o tratamento do linfoma de células do manto
US20080125377A1 (en) Delivery system for antiangiogenic and antiinflammatory pharmaceuticals and method of use
HK40044057A (zh) 包含奈必洛尔的药物组合物
HK40082670A (zh) 局部眼科组合物和治疗异常血管新生的方法
HK1117391A (zh) 用於眼治疗的制剂